BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 32295865)

  • 1. Requirement for cleavage factor II
    Turner RE; Henneken LM; Liem-Weits M; Harrison PF; Swaminathan A; Vary R; Nikolic I; Simpson KJ; Powell DR; Beilharz TH; Dichtl B
    RNA; 2020 Aug; 26(8):969-981. PubMed ID: 32295865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length.
    Martin G; Gruber AR; Keller W; Zavolan M
    Cell Rep; 2012 Jun; 1(6):753-63. PubMed ID: 22813749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of mammalian cleavage factor II involved in 3' processing of mRNA precursors.
    Schäfer P; Tüting C; Schönemann L; Kühn U; Treiber T; Treiber N; Ihling C; Graber A; Keller W; Meister G; Sinz A; Wahle E
    RNA; 2018 Dec; 24(12):1721-1737. PubMed ID: 30139799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage factor Im is a key regulator of 3' UTR length.
    Gruber AR; Martin G; Keller W; Zavolan M
    RNA Biol; 2012 Dec; 9(12):1405-12. PubMed ID: 23187700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
    Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
    Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Regulation of Alternative Polyadenylation (APA) within the Drosophila Nervous System.
    Vallejos Baier R; Picao-Osorio J; Alonso CR
    J Mol Biol; 2017 Oct; 429(21):3290-3300. PubMed ID: 28366829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the yeast cleavage and polyadenylation factor subunit Ydh1p/Cft2p in pre-mRNA 3'-end formation.
    Kyburz A; Sadowski M; Dichtl B; Keller W
    Nucleic Acids Res; 2003 Jul; 31(14):3936-45. PubMed ID: 12853609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPEB1 coordinates alternative 3'-UTR formation with translational regulation.
    Bava FA; Eliscovich C; Ferreira PG; Miñana B; Ben-Dov C; Guigó R; Valcárcel J; Méndez R
    Nature; 2013 Mar; 495(7439):121-5. PubMed ID: 23434754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.
    Fu Y; Sun Y; Li Y; Li J; Rao X; Chen C; Xu A
    Genome Res; 2011 May; 21(5):741-7. PubMed ID: 21474764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome Analyses of FY Mutants Reveal Its Role in mRNA Alternative Polyadenylation.
    Yu Z; Lin J; Li QQ
    Plant Cell; 2019 Oct; 31(10):2332-2352. PubMed ID: 31427469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent molecular insights into canonical pre-mRNA 3'-end processing.
    Sun Y; Hamilton K; Tong L
    Transcription; 2020 Apr; 11(2):83-96. PubMed ID: 32522085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstitution of 3' end processing of mammalian pre-mRNA reveals a central role of RBBP6.
    Schmidt M; Kluge F; Sandmeir F; Kühn U; Schäfer P; Tüting C; Ihling C; Conti E; Wahle E
    Genes Dev; 2022 Feb; 36(3-4):195-209. PubMed ID: 35177537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of 3' end sequencing data sets reveals novel polyadenylation signals and the repressive role of heterogeneous ribonucleoprotein C on cleavage and polyadenylation.
    Gruber AJ; Schmidt R; Gruber AR; Martin G; Ghosh S; Belmadani M; Keller W; Zavolan M
    Genome Res; 2016 Aug; 26(8):1145-59. PubMed ID: 27382025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic profiling of poly(A)+ transcripts modulated by core 3' end processing and splicing factors reveals regulatory rules of alternative cleavage and polyadenylation.
    Li W; You B; Hoque M; Zheng D; Luo W; Ji Z; Park JY; Gunderson SI; Kalsotra A; Manley JL; Tian B
    PLoS Genet; 2015 Apr; 11(4):e1005166. PubMed ID: 25906188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combinatorial code for mRNA 3'-UTR-mediated translational control in the mouse oocyte.
    Dai XX; Jiang JC; Sha QQ; Jiang Y; Ou XH; Fan HY
    Nucleic Acids Res; 2019 Jan; 47(1):328-340. PubMed ID: 30335155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation.
    Hardy JG; Norbury CJ
    Biochem Soc Trans; 2016 Aug; 44(4):1051-7. PubMed ID: 27528751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
    Kim N; Chung W; Eum HH; Lee HO; Park WY
    PLoS One; 2019; 14(5):e0217196. PubMed ID: 31100099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.